Trial Profile
Phase I Study of Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Jan 2024
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary) ; Metformin
- Indications Cancer; Carcinoma; Endometrial cancer
- Focus Adverse reactions
- 05 Apr 2023 Planned End Date changed from 1 Oct 2022 to 1 Jun 2024.
- 05 Apr 2023 Planned primary completion date changed from 1 Oct 2022 to 1 Jun 2024.
- 22 Nov 2021 Planned End Date changed from 1 Mar 2020 to 1 Oct 2022.